Summary
HCA Healthcare, Inc. reported strong financial performance for the first quarter of 2012, with revenues increasing by 13.5% to $8.4 billion compared to the same period in 2011. This growth was driven by a 11.4% increase in equivalent admissions and a 1.9% rise in revenue per equivalent admission, partly bolstered by the full consolidation of the HCA-HealthONE LLC venture. Net income attributable to HCA Holdings, Inc. significantly improved, reaching $540 million ($1.18 per diluted share) from $240 million ($0.52 per diluted share) in the prior year. This improvement was aided by substantial Medicare revenue adjustments totaling $188 million, though partially offset by a retroactive reduction of $83 million. The company also benefited from a decrease in interest expense by $91 million due to a lower average effective interest rate on its debt. However, cash flows from operations saw a decline primarily due to changes in working capital. HCA Healthcare continues to manage its significant debt load and is actively engaged in capital allocation, including a $971 million distribution to stockholders declared in February 2012. The company maintains a positive outlook, anticipating continued revenue growth and managing operational costs, while also addressing ongoing legal and regulatory matters.
Financial Highlights
45 data points| Revenue | $8.40B |
| Interest Expense | $442.00M |
| Net Income | $540.00M |
| EPS (Basic) | $1.23 |
| EPS (Diluted) | $1.18 |
| Shares Outstanding (Basic) | 437.94M |
| Shares Outstanding (Diluted) | 458.31M |
Key Highlights
- 1Revenues increased 13.5% year-over-year to $8.4 billion in Q1 2012.
- 2Net income attributable to HCA Holdings, Inc. more than doubled to $540 million ($1.18/share) from $240 million ($0.52/share) in Q1 2011.
- 3Significant Medicare revenue adjustments of $188 million positively impacted Q1 2012 results.
- 4Interest expense decreased by $91 million due to lower average effective interest rates on debt.
- 5Total equivalent admissions increased by 11.4%, indicating robust patient volume growth.
- 6The company declared a $2.00 per share distribution to stockholders, totaling approximately $971 million.
- 7Cash flows from operations decreased by $121 million, primarily due to changes in working capital.